Patents by Inventor Dawn Coverley

Dawn Coverley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Replication protein
    Patent number: 9541555
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: January 10, 2017
    Assignee: Cizzle Biotech Limited
    Inventor: Dawn Coverley
  • REPLICATION PROTEIN
    Publication number: 20160011200
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Application
    Filed: February 5, 2015
    Publication date: January 14, 2016
    Applicant: CIZZLE BIOTECHNOLOGY LIMITED
    Inventor: Dawn Coverley
  • REPLICATION PROTEIN
    Publication number: 20110070591
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Application
    Filed: September 22, 2010
    Publication date: March 24, 2011
    Applicant: CIZZLE BIOTECHNOLOGY LIMITED
    Inventor: Dawn COVERLEY
  • Replication protein
    Patent number: 7833702
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: November 16, 2010
    Assignee: Cizzle Biotechnology Limited
    Inventor: Dawn Coverley
  • Replication protein
    Publication number: 20060155113
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 13, 2006
    Inventor: Dawn Coverley